Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Boswellia thurifera is a species of the Boswellia genus known for its gum resin, commonly referred to as frankincense. The gum resin is used traditionally in Ayurveda and other folk medicines. The main active compounds in Boswellia extracts are **boswellic acids**, which exhibit **anti-inflammatory**, **antiarthritic**, and **analgesic** activities. These actions are primarily due to inhibition of the **5-lipoxygenase (5-LO)** enzyme, leading to reduced leukotriene synthesis, as well as inhibition of cyclooxygenase-1 (COX-1) and nuclear factor-kappaB (NF-κB) signaling[4][5][7]. Boswellia is used for conditions such as osteoarthritis, rheumatoid arthritis, inflammatory bowel disease, asthma, and certain cancers. It may be administered orally or topically.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on boswellia thurifera.